Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer

Author： Gierach Gretchen   Loud Jennifer  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.123, Iss.1, 2010-08, pp. : 245-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies

By Yu Ke-Da  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 365-371

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

By Reding Kerryn  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 491-498

Springer Publishing Company

Access to resources Recommend Favorite

The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

By Kaufman Bella  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 521-527

Springer Publishing Company

Access to resources Recommend Favorite

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 241-242

Informa Healthcare

Access to resources Recommend Favorite

Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

By Kotsopoulos Joanne  

Cancer Causes and Control, Vol. 16, Iss. 6, 2005-08 ,pp. : 667-674

Springer Publishing Company

Access to resources Recommend Favorite